Yiming Miao
Overview
Explore the profile of Yiming Miao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
208
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Dong J, Miao J, Miao Y, Qu Z, Zhang S, Zhu P, et al.
Angew Chem Int Ed Engl
. 2023 Mar;
62(22):e202303818.
PMID: 36973833
Protein tyrosine phosphatase 1B (PTP1B) and T-cell protein tyrosine phosphatase (TC-PTP) play non-redundant negative regulatory roles in T-cell activation, tumor antigen presentation, insulin and leptin signaling, and are potential targets...
12.
Bai Y, Yu G, Zhou H, Amarasinghe O, Zhou Y, Zhu P, et al.
Autophagy
. 2022 Oct;
19(5):1562-1581.
PMID: 36300783
Overexpression of PTP4A phosphatases are associated with advanced cancers, but their biological functions are far from fully understood due to limited knowledge about their physiological substrates. VCP is implicated in...
13.
Blaine A, Miao Y, Yuan J, Palant S, Liu R, Zhang Z, et al.
Front Pharmacol
. 2022 Sep;
13:914651.
PMID: 36059958
The δ-opioid receptor (δOR) has been considered as a therapeutic target in multiple neurological and neuropsychiatric disorders particularly as δOR agonists are deemed safer alternatives relative to the more abuse-liable...
14.
Zong Y, Miao Y, Li W, Zheng M, Xu Z, Gao H, et al.
J Cell Mol Med
. 2022 May;
26(12):3471-3482.
PMID: 35579380
Colorectal cancer (CRC) is a worldwide disease with worse survival. Our objective is to identify previously unrecognized prognostic factors to better evaluate disease progression. Seven GEO datasets were collected and...
15.
Zhang Y, Xu Z, Feng W, Gao H, Xu Z, Miao Y, et al.
Clin Transl Med
. 2022 Apr;
12(4):e812.
PMID: 35415883
No abstract available.
16.
Shen X, Zhang Y, Xu Z, Gao H, Feng W, Li W, et al.
Cell Death Dis
. 2022 Apr;
13(4):303.
PMID: 35379798
Oxaliplatin resistance is a major challenge in the treatment of colorectal cancer (CRC). Many molecular targeted drugs for refractory CRC have been developed to solve CRC drug resistance, but their...
17.
Xu Z, Gao H, Zhang Y, Feng W, Miao Y, Xu Z, et al.
Mol Ther
. 2022 Mar;
30(6):2327-2341.
PMID: 35283273
CXCL5 is overexpressed in colorectal cancer (CRC) and promotes distant metastasis and angiogenesis of tumors; however, the underlying mechanism that mediates CXCL5 overexpression in CRC remains unclear. Here, we successfully...
18.
Sun X, Qiao H, Cheng X, Tian H, Shen K, Jin W, et al.
Front Endocrinol (Lausanne)
. 2021 Dec;
12:766209.
PMID: 34917028
Andersson lesions (ALs) in ankylosing spondylitis (AS) pose a severe risk to the stability of ankylosed spine, which might result in significant deterioration of spinal cord function after traumatic or...
19.
Lu W, Wang Q, Xue Y, Gu J, Yao P, Ge Y, et al.
Comput Math Methods Med
. 2021 Nov;
2021:3562942.
PMID: 34777562
Osteoporosis is a degenerative osteoarthropathy commonly found in old people and postmenopausal women. Many studies showed that microRNAs (miRNAs) can regulate the expression of osteoporosis-related genes and are abnormally expressed...
20.
Wang Q, Miao Y, Qian Z, Chen L, Lu T, Xu Y, et al.
Bioengineered
. 2021 Oct;
12(1):8173-8185.
PMID: 34672248
Osteoporosis is defined as a bone condition characterized by bone mass reduction, bone micro-architectural and quality deterioration, leading to compromised strength and increased chances of fracture. Evidence have shown an...